Mariner
IMCR icon

Mariner’s Immunocore IMCR Stock Holding History

Mariner’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,139
Closed -$242K – 3343
2024
Q2 		$242K Buy
7,139
+1,484
+26% +$75.7K ﹤0.01% 2632
2024
Q1 		$368K Buy
5,655
+365
+7% +$25K ﹤0.01% 2274
2023
Q4 		$361K Buy
5,290
+959
+22% +$49.8K ﹤0.01% 2187
2023
Q3 		$225K Buy
4,331
+599
+16% +$35.5K ﹤0.01% 2413
2023
Q2 		$223K Buy
+3,732
New +$213K ﹤0.01% 2370

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Mariner's IMCR Position: Q3 2024 in Review

Mariner sold out of Immunocore (IMCR) in Q3 2024, closing a stake of 7,139 shares — an estimated $242K sold.

Mariner first reported a position in IMCR in Q2 2023 and held it in 5 quarters. The position peaked at $368K in Q1 2024. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2024.

  • Mariner reported no remaining Immunocore position as of Q3 2024 after selling out during the quarter.
  • Mariner sold 7,139 Immunocore shares in Q3 2024, an estimated $242K.
  • Mariner first reported a position in Immunocore in Q2 2023 and held it in 5 quarters.
  • Mariner's Immunocore position peaked at $368K in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2024.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.